14.alpha.-hydroxy-4-androstene-3,6,17-trione hydrate crystal and

Organic compounds -- part of the class 532-570 series – Organic compounds – Cyclopentanohydrophenanthrene ring system containing

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 60, C07J 100

Patent

active

056146515

ABSTRACT:
Provided are stable hydrate crystals of 14.alpha.-hydroxy-4-androstene-3,6,17-trione having a biological activity of human placenta-originating estrodiene synthesis enzyme inhibitory action. These hydrate crystals include two kinds of 14.alpha.-hydroxy-4-androstene-3,6,17-trione hydrate crystals having a diffraction pattern having characteristic peaks at diffraction angles in crystalline powder X-ray diffraction. Processes for producing these hydrate crystals are also provided.

REFERENCES:
patent: 4975368 (1990-12-01), Yoshihama et al.
patent: 5098535 (1992-03-01), Nakakoshi et al.
Remmington's Pharmaceutical Sciences, 15th edition, 1975, p. 1358.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

14.alpha.-hydroxy-4-androstene-3,6,17-trione hydrate crystal and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 14.alpha.-hydroxy-4-androstene-3,6,17-trione hydrate crystal and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 14.alpha.-hydroxy-4-androstene-3,6,17-trione hydrate crystal and will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2204683

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.